Pharmaceuticals

Govt’s Amrut Scheme to make 2,000 medicines cheaper by up to 90%

07 Nov 2016

Dr Reddy's, Sun Pharma under cartelisation probe in US

05 Nov 2016

Abbott offers EU concessions for antitrust approval of St Jude Medical acquisition

04 Nov 2016

US regulator targets generic drugmakers for price fixing

04 Nov 2016

Former Sprout Pharma investors sue Valeant Pharmaceuticals over failure of female Viagara

04 Nov 2016

Female viagara maker Palatin Technologies explores sale

03 Nov 2016

Valeant explores sale of eye-surgery equipment business worth around $2.5 bn

03 Nov 2016

Valeant Pharmaceuticals in discussion with Takeda for Salix sale: report

03 Nov 2016

DRI seizes 23.5 tonnes of Mandrax tablets worth Rs3,000 cr

02 Nov 2016

Mylan’s price hike on EpiPens adds millions to DoD spending

31 Oct 2016

J&J loses third lawsuit over talcum powder link to ovarian cancer

29 Oct 2016

Johnson & Johnson, which is facing over 1,700 lawsuits in state and federal courts over ignoring studies linking its baby powder and Shower-to-Shower talc products to ovarian cancer, has been asked to pay a California woman more than $70 million in damages

Sun Pharma to acquire US-based Ocular Technologies for $40 million

28 Oct 2016

Mylan NV’s EpiPen to get completion from rival Kaleo Inc’s Auvi-Q

27 Oct 2016

NPPA struggles to get pricing data from medical devices firms

19 Oct 2016

Japan’s Terumo to buy some medical devices from Abbott and St. Jude Medical for $1.12 bn

18 Oct 2016

BSN Medical sale may fetch EQT Partners around $3.4 bn

15 Oct 2016

Over half a million heart surgery patients at risk of deadly infection

15 Oct 2016

Lupin, BC Partners shortlisted for Bayer’s $1.1 bn dermatology business

14 Oct 2016

Lupin is mainly attracted by the Bayer dermatology business's regional presence in North America, where it is keen to expand

Battery defect in St Jude’s heart defibrillators causes 2 deaths

13 Oct 2016

Piramal Enterprises to buy five injectable products from Janssen NV

10 Oct 2016

NPPA caps prices of 31 essential drugs

10 Oct 2016

From Edison to miniLab, but scepticism still surrounds Theranos

10 Oct 2016

Novartis to take on Pfizer’s Ibrance with Ribociclib for breast cancer

10 Oct 2016

Mylan to pay $465 mn to settle DoJ probe over EpiPen costs

08 Oct 2016

Generic and specialty pharmaceuticals company Mylan NV yesterday agreed to pay $465 million to settle allegations of overcharging the US government on its Medicaid program for its EpiPen products

Pfizer to sell global infusion therapy business to ICU Medical for $1 bn

07 Oct 2016